Disclaimer

Highest Rated Articles

Conjeevaram HS, Fried MW, Jeffers LJ et al. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology. 131(2):470-7, 2006 Aug.

Sanchez-Tapias JM, Diago M, Escartin P et al. Peginterferon-alfa2a plus
ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment. Gastroenterology. 131(2):451-60, 2006 Aug.



Di Liberto G, Roque-Afonso AM, Kara R et al. Clinical and therapeutic
implications of hepatitis C virus compartmentalization. Gastroenterology. 131(1):76-84, 2006 Jul.

Hwang LY, Kramer JR, Troisi C et al. Relationship of cosmetic procedures and
drug use to hepatitis C and hepatitis B virus infections in a low-risk population. Hepatology. 44(2):341-51, 2006 Aug.

Thorburn D, Roy K, Wilson K et al. Anonymous pilot study of hepatitis C virus
prevalence in liver transplant surgeons. Liver Transplantation. 12(7):1084-8, 2006 Jul.

Ercolani G, Grazi GL, Ravaioli M, et al. Histological recurrent hepatitis C after
liver transplantation: Outcome and role of retransplantation. Liver Transplantation. 12(7):1104-11, 2006 Jul.

Fox RK, Currie SL, Evans J. Hepatitis C virus infection among prisoners in the
California state correctional system. Clin Infect Dis. 41(2):177-86, 2005 Jul 15.

American Journal of Gastroenterology
Rating	Article Title
	Verma S, Bonacini M, Govindarajan S et al. More advanced hepatic fibrosis in hispanics with chronic hepatitis C infection: role of patient demographics, hepatic necroinflammation, and steatosis. Am J Gastroenterol. 101(8):1817-23, 2006 Aug.
	Ciancio A, Smedile A, Giordanino C et al. Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured? Am J Gastroenterol. 101(8):1811-6, 2006 Aug.
	Libman H, Saitz R, Nunes D et al. Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problems. Am J Gastroenterol. 101(8):1804-10, 2006 Aug.
	Monto A, Kakar S, Dove LM., Bostrom A, Miller EL, Wright TL. Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients. Am J Gastroenterol. 101(7):1509-15, 2006 Jul.
	Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol. 101(7):1490-6, 2006 Jul.
Clinical Infectious Disease
Rating	Article Title
	McGovern BH, Ditelberg JS, Taylor LE et al. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis. 43(3):365-72, 2006 Aug 1.
	Miller MF, Haley C, Koziel MJ, Rowley CF. Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis. 41(5):713-20, 2005 Sep 1.
	Netski DM, Mosbruger T, Depla E et al. Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis. 41(5):667-75, 2005 Sep 1.
	Sanchez-Conde M, Berenguer J, Miralles P. Liver biopsy findings for HIV- infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase. Clin Infect Dis. 43(5):640-4, 2006 Sep 1.
	Arcari CM, Nelson KE, Netski DM, Nieto FJ, Gaydos CA. No association between hepatitis C virus seropositivity and acute myocardial infarction. Clin Infect Dis. 43(6):e53-6, 2006 Sep 15.
European Journal of Gastroenterology and Hepatology
Rating	Article Title
	Delwaide J, Reenaers C, Gerard C et al. HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin. Eur J Gastroenterol Hepatol. 18(7):707-12, 2006 Jul.
	Wietzke-Braun P, Maouzi AB, Manhardt LB, Bickeboller H, Ramadori G, Mihm S. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection. Eur J Gastroenterol Hepatol. 18(9):991-7, 2006 Sep.
Gastroenterology
Rating	Article Title
	Fried MW, Kroner BL, Preiss LR, Wilhelmsen K, Goedert JJ. Hemophilic siblings with chronic hepatitis C: familial aggregation of spontaneous and treatment-related viral clearance. Gastroenterology. 131(3):757-64, 2006 Sep.
	Nainan OV, Alter MJ, Kruszon-Moran D et al. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States. Gastroenterology. 131(2):478-84, 2006 Aug.
Hepatology
Rating	Article Title
	He XS, Ji X, Hale MB et al. Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology. 44(2):352-9, 2006 Aug.
	Morishima C, Morgan TR, Everhart JE et al. HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial. Hepatology. 44(2):360-7, 2006 Aug.
	Gopal K, Johnson TC, Gopal S, et al. Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment. Hepatology. 44(2):335-40, 2006 Aug.
	Ikeda M, Abe K, Yamada M, Dansako H, Naka K, Kato N. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology. 44(1):117-25, 2006 Jul.
	Puig M, Mihalik K, Tilton JC et al. CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus. Hepatology. 44(3):736-45, 2006 Sep.
	Barth H, Liang TJ, Baumert TF. Hepatitis C virus entry: Molecular biology and clinical implications. Hepatology. 44(3):527-35, 2006 Sep.
	Diamond DL. Proll SC, Jacobs JM et al. HepatoProteomics: applying proteomic technologies to the study of liver function and disease. Hepatology. 44(2):299-308, 2006 Aug.
	Urbani S, Amadei B, Fisicaro P et al. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology. 44(1):126-39, 2006 Jul.
	Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: Insights into clinical manifestations and biological consequences. Hepatology. 44(1):15-22, 2006 Jul.
Journal Acquired Immune Deficiency Syndrome
Rating	Article Title
	Bower WA, Culver DH, Castor D et al. Changes in hepatitis C virus (HCV) viral load and interferon-alpha levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 42(3):293-7, 2006 Jul.
	Franceschini N, Napravnik S, Finn WF, Szczech LA, Eron JJ Jr. Immunosuppression, hepatitis C infection, and acute renal failure in HIV-infected patients. J Acquir Immune Defic Syndr. 42(3):368-72, 2006 Jul.
Liver Transplantation
Rating	Article Title
	Barshes NR, Udell IW, Lee TC et al. The natural history of hepatitis C virus in pediatric liver transplant recipients. Liver Transplantation. 12(7):1119-23, 2006 Jul.
	Terrault NA, Berenguer M. Treating hepatitis C infection in liver transplant recipients. Liver Transplantation. 12(8):1192-204, 2006 Aug.
	Schiano TD, Charlton M, Younossi Z et al. Monoclonal antibody HCV-Ab(XTL)68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study. Liver Transplantation. 12(9):1381-9, 2006 Sep.
	Servin-Abad L, Tzakis A, Schiff ER et al. Acquired hepatocerebral degeneration in a patient with HCV cirrhosis: complete resolution with subsequent recurrence after liver transplantation. Liver Transplantation. 12(7):1161-5, 2006 Jul.
	Berenguer M, Palau A, Fernandez A et al. Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C. Liver Transplantation. 12(7):1067-76, 2006 Jul.